XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-based Compensation Expense (Tables)
6 Months Ended
Jun. 30, 2022
Summary of Stock Option Activity The following table summarizes the Company’s stock option activity during the six months ended June 30, 2022:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise Price

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2021

 

 

5,188,354

 

 

$

13.91

 

 

 

8.57

 

 

$

27,082,052

 

Granted

 

 

2,253,030

 

 

 

12.77

 

 

 

 

 

 

 

Exercised

 

 

(349,871

)

 

 

8.59

 

 

 

 

 

 

 

Cancelled

 

 

(953,773

)

 

 

16.35

 

 

 

 

 

 

 

Outstanding at June 30, 2022

 

 

6,137,740

 

 

$

13.42

 

 

 

8.09

 

 

$

3,971

 

Exercisable at June 30, 2022

 

 

1,786,579

 

 

$

11.92

 

 

 

6.72

 

 

$

3,967

 

Weighted Average Assumptions Used to Calculate Fair Value of Stock Option The fair value of stock options granted during the three and six months ended June 30, 2022 and 2021 has been calculated on the date of grant using the following weighted average assumptions:

 

 

 

Three Months
Ended
June 30, 2022

 

 

Three Months
Ended
June 30, 2021

 

 

Six Months
Ended
June 30, 2022

 

 

Six Months
Ended
June 30, 2021

 

Risk-free interest rate

 

 

3.0

%

 

 

1.0

%

 

 

2.0

%

 

 

0.9

%

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

Expected term (years)

 

 

6.0

 

 

 

6.0

 

 

 

6.0

 

 

 

6.0

 

Expected stock price volatility

 

 

88.0

%

 

 

86.9

%

 

 

88.4

%

 

 

86.2

%

Summary of Stock-Based Compensation Expense Recognized

The total compensation cost recognized in the statements of operations and comprehensive loss associated with all stock-based compensation awards granted by the Company is as follows (in thousands):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

General and administrative

 

$

2,076

 

 

$

1,562

 

 

$

4,541

 

 

$

2,846

 

Research and development

 

 

803

 

 

 

984

 

 

 

2,185

 

 

 

1,773

 

Total stock-based compensation expense

 

$

2,879

 

 

$

2,546

 

 

$

6,726

 

 

$

4,619

 

2019 Plan and 2016 Plan  
Summary of Restricted Stock Activity

The following table summarizes the Company’s restricted stock award activity during the six months ended June 30, 2022:

 

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair
Value

 

Unvested at December 31, 2021

 

 

10,174

 

 

$

3.35

 

Granted

 

 

 

 

 

 

Vested

 

 

(10,174

)

 

 

3.35

 

Repurchased

 

 

 

 

 

 

Unvested at June 30, 2022

 

 

 

 

$

 

Grants Outside of 2016 Stock Incentive Plan and 2019 Stock Incentive Plan  
Summary of Restricted Stock Activity

The Company has also granted restricted stock units. The shares of common stock underlying restricted stock units typically vest over a four-year period. The shares of common stock are recorded in stockholders’ equity as they vest.

The following table summarizes the Company’s restricted stock unit activity during the six months ended June 30, 2022:

 

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair
Value

 

Unvested at December 31, 2021

 

 

 

 

$

 

Granted

 

 

126,803

 

 

 

10.09

 

Vested

 

 

 

 

 

 

Cancelled

 

 

(11,614

)

 

 

11.72

 

Unvested at June 30, 2022

 

 

115,189

 

 

$

9.93